Peter Pal Du Boulay Villax
Président chez Bionova Capital SCR SA
Profil
Peter Pal Du Boulay Villax is currently the Chairman at Bionova Capital SCR SA, Director at Proterris (Portugal) -.
Investigação e Desenvolvimento, and Vice President at The United States Pharmacopeia.
He was previously the Executive Vice President at Hovione Farmaciência SA. He graduated from the University of Aberdeen.
Postes actifs de Peter Pal Du Boulay Villax
| Sociétés | Poste | Début |
|---|---|---|
Proterris (Portugal) - Investigação e Desenvolvimento
 Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal. | Directeur/Membre du Conseil | 09/09/2009 |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Corporate Officer/Principal | 23/07/2010 |
Bionova Capital SCR SA
 Bionova Capital SCR SA Investment ManagersFinance Bionova Capital SCR SA. (Bionova Capital) is a venture capital firm founded in 2015. It was previously known as Hovione Capital. The firm is headquartered in Lisbon, Portugal. | Président | 01/03/2016 |
Anciens postes connus de Peter Pal Du Boulay Villax
| Sociétés | Poste | Fin |
|---|---|---|
Hovione Farmaciência SA
 Hovione Farmaciência SA Pharmaceuticals: MajorHealth Technology Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal. | Corporate Officer/Principal | - |
Formation de Peter Pal Du Boulay Villax
| University of Aberdeen | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Proterris (Portugal) - Investigação e Desenvolvimento
Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal. | Health Technology |
Hovione Farmaciência SA
Hovione Farmaciência SA Pharmaceuticals: MajorHealth Technology Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal. | Health Technology |
The United States Pharmacopeia
The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Health Technology |
Bionova Capital SCR SA
Bionova Capital SCR SA Investment ManagersFinance Bionova Capital SCR SA. (Bionova Capital) is a venture capital firm founded in 2015. It was previously known as Hovione Capital. The firm is headquartered in Lisbon, Portugal. | Finance |
